TSX:MDP (Canada)  
Medexus Pharmaceuticals Inc logo

Medexus Pharmaceuticals Inc

C$ 1.06 (+8.16%) Oct 5
P/E:
7.73
P/B:
0.94
Market Cap:
C$ 21.15M ($ 15.58M)
Enterprise V:
C$ 88.99M ($ 65.54M)
Volume:
56.06K
Avg Vol (2M):
63.99K
Also Trade In:
Volume:
56.06K
Market Cap C$:
21.15M
Market Cap $:
15.58M
PE Ratio:
7.73
Avg Vol (2-Month):
63.99K
Enterprise Value C$:
88.99M
Enterprise Value $:
65.54M
PB Ratio:
0.94
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

Description
Medexus Pharmaceuticals Inc is an innovative and rare disease pharmaceutical company with a strong North American commercial platform and a portfolio of proven best-in-class products. The company's focus is on the therapeutic areas of hematology, auto-immune diseases, and allergy.
Name Current Vs Industry Vs History
Cash-To-Debt 0.13
Equity-to-Asset 0.13
Debt-to-Equity 3.27
Debt-to-EBITDA 2.92
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0.31
Distress
Grey
Safe
Beneish M-Score -3.3
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 48.75
9-Day RSI 33.31
14-Day RSI 30.46
6-1 Month Momentum % -21.02
12-1 Month Momentum % -19.74

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.97
Quick Ratio 0.53
Cash Ratio 0.15
Days Inventory 163.81
Days Sales Outstanding 64.8
Days Payable 210.53

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -10.6

Financials

TSX:MDP's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil C$) 105.069
EPS (TTM) (C$) 0.137
Beta 1.84
Volatility % 78.38
14-Day RSI 30.46
14-Day ATR (C$) 0.166961
20-Day SMA (C$) 1.405
12-1 Month Momentum % -19.74
52-Week Range (C$) 0.88 - 3.86
Shares Outstanding (Mil) 19.95

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Medexus Pharmaceuticals Inc Filings

Document Form Filing Date
No Filing Data

Medexus Pharmaceuticals Inc Analysis

Share your research